comparemela.com

Latest Breaking News On - ஸ்டீபன் வில்லியம்சன் - Page 2 : comparemela.com

Thermo Fisher Scientific Inc (TMO) Q1 2021 Earnings Call Transcript

Operator Good morning, ladies and gentlemen, and welcome to the Thermo Fisher Scientific 2021 First Quarter Conference Call. [Operator Instructions] [Operator Instructions] I would now like to introduce our moderator for the call, Mr. Rafael Tejada, Vice President, Investor Relations. Mr. Tejada, you may begin the call. Rafael Tejada Vice President, of Investor Relations. Good morning, and thank you for joining us. On the call with me today is Marc Casper, our Chairman, President and Chief Executive Officer; and Stephen Williamson, Senior Vice President and Chief Financial Officer. Please note this call is being webcast live and will be archived on the Investors section of our website, thermofisher.com, under the heading Webcast and Presentations until May 14, 2021. A copy of the press release of our first quarter 2021 earnings is available in the Investors section of our website under the heading Financial Results. So before we begin, let me briefly cover our safe harbor sta

MusicalAmerica - MA s Free Guide to (Mostly) Free Streams, April 19-26

MusicalAmerica - MA s Free Guide to (Mostly) Free Streams, April 19-26
musicalamerica.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from musicalamerica.com Daily Mail and Mail on Sunday newspapers.

MusicalAmerica - MA s Free Guide to (Mostly) Free Streams, April 19-26

MusicalAmerica - MA s Free Guide to (Mostly) Free Streams, April 19-26
musicalamerica.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from musicalamerica.com Daily Mail and Mail on Sunday newspapers.

Thermo Fisher s $21B deal for PPD gives it missing piece in drug development cycle

MedCity News Thermo Fisher’s $21B deal for PPD gives it missing piece in drug development cycle Thermo Fisher Scientific sells laboratory equipment used in drug research and it also offers manufacturing services for experimental and commercialized drugs. By acquiring PPD, Thermo Fisher says it will gain capabilities in the growing global market of clinical trial services. Shares0   Thermo Fisher Scientific sells the laboratory equipment that biopharmaceutical companies use in the research and development of new drugs. Its $20.9 billion acquisition of PPD will give the company the global infrastructure to run the clinical trials that test them. Waltham, Massachusetts-based Thermo Fisher announced Thursday that it has agreed to pay $17.4 billion cash for PPD, breaking down to $47.50 for each share of the company. That price represents a premium of about 24% to PPD’s closing stock price on Tuesday, before news surfaced about a potential deal. Shares of PPD, a pharmaceutical

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.